Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory Breast Cancer.

International journal of molecular sciences - 14 Feb 2020

Winn Jennifer S, Hasse Zachary, Slifker Michael, Pei Jianming, Arisi-Fernandez Sebastian M, Talarchek Jacqueline N, Obeid Elias, Baldwin Donald A, Gong Yulan, Ross Eric, Cristofanilli Massimo, Alpaugh R Katherine, Fernandez Sandra V

Abstract excerpt

We studied genomic alterations in 19 inflammatory breast cancer (IBC) patients with advanced disease using samples of tissue and paired blood serum or plasma (cell-free DNA, cfDNA) by targeted next generation sequencing (NGS). At diagnosis, the disease was triple negative (TN) in eleven patients (57.8%), ER+ Her2- IBC in six patients (31.6%), ER+ Her2+ IBC in one patient (5.3%), and ER- Her2+ IBC in one other...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell-Free Nucleic Acids

Share to Gene Frequency

Share to High-Throughput Nucleotide Sequencing

Share to Mismatch Repair Endonuclease PMS2

Share to Neoplasm Staging

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 32075053
DOI: 10.3390/ijms21041290
PMCID: PMC7072950

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory Breast Cancer.PMID 32075053Read ↗

Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC).Semantic proximity Read ↗

Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.Semantic proximity Read ↗

Clinicogenomic characterization of inflammatory breast cancerSemantic proximity Read ↗

NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.Semantic proximity Read ↗

Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations.Semantic proximity Read ↗

Targeted Sequencing of Plasma-Derived vs. Urinary cfDNA from Patients with Triple-Negative Breast CancerSemantic proximity Read ↗

Inflammatory Breast Cancer: Clinical Implications of Genomic Alterations and Mutational ProfilingSemantic proximity Read ↗

Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers.Semantic proximity Read ↗

BRCA mutations in women with inflammatory breast cancer.Semantic proximity Read ↗

Comprehensive Genomic Profiling of Cell-Free Circulating Tumor DNA Detects Response to Ribociclib Plus Letrozole in a Patient with Metastatic Breast Cancer.Semantic proximity Read ↗

Evaluation of cfDNA as an early detection assay for dense tissue breast cancer.Semantic proximity Read ↗

Detection of genomic alterations in breast cancer with circulating tumour DNA sequencingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.